Shobhit Gairola

Employment

Employment history is unavailable.

Education

• National Institute of Pharmaceutical Education and Research M.S. (Pharm.)
  2019 - 2021

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Biochanin A Ameliorates Nephropathy in High-Fat Diet/Streptozotocin-Induced Diabetic Rats: Effects on NF-kB/NLRP3 Axis, Pyroptosis, and Fibrosis
  Antioxidants 2023 DOI: 10.3390/antiox12051052
  +Save
• Biological Activities, Pharmacokinetics and Toxicity of Nootkatone: A Review
  Mini-Reviews in Medicinal Chemistry 2022 DOI: 10.2174/1389557522666220214092005
  +Save
• Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-β1/Smad2/3 and NF-kB/NLRP3 signaling axis in mice
  Life Sciences 2022 DOI: 10.1016/j.lfs.2022.120527
  +Save
• Carvacrol preserves antioxidant status and attenuates kidney fibrosis via modulation of TGF-β1/Smad signaling and inflammation
  Food & Function 2022 DOI: 10.1039/d2fo01384c
  +Save
• Nootkatone confers antifibrotic effect by regulating the TGF-β/Smad signaling pathway in mouse model of unilateral ureteral obstruction
  European Journal of Pharmacology 2021 DOI: 10.1016/j.ejphar.2021.174479
  +Save
• Toll-like receptor 4: An attractive therapeutic target for acute kidney injury
  Life Sciences 2021 DOI: 10.1016/j.lfs.2021.119155
  +Save
• Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches
  European Journal of Pharmacology 2020 DOI: 10.1016/j.ejphar.2020.173503
  +Save